CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone

被引:1
|
作者
Bose, Sminu [1 ]
Lee, Tristan [2 ]
Choi, Shaelyn [1 ]
Fazlollahi, Ladan [3 ]
Rasiej, Michael J. [4 ]
Schwartz, Gary K. [1 ]
Ingham, Matthew [1 ]
机构
[1] Columbia Univ, Irving Med Ctr, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA
[4] Columbia Univ, Irving Med Ctr, Dept Radiol, New York, NY USA
关键词
PEGYLATED-LIPOSOMAL DOXORUBICIN; PHASE-II; KINASE; VINCRISTINE; BLEOMYCIN; TRIAL; PD-L1; CDK6;
D O I
10.1200/PO.21.00550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
    Tan, Shuguang
    Zhang, Catherine W-H
    Gao, George F.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2016, 1
  • [22] Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
    Shuguang Tan
    Catherine W-H Zhang
    George F Gao
    Signal Transduction and Targeted Therapy, 1
  • [23] Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma
    Kaehler, Katharina C.
    Hassel, Jessica C.
    Heinzerling, Lucie
    Loquai, Carmen
    Moessner, Rotraut
    Ugurel, Selma
    Zimmer, Lisa
    Gutzmer, Ralf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (07): : 662 - 681
  • [24] Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
    Hassel, Jessica C.
    Heinzerling, Lucie
    Aberle, Jens
    Baehr, Oliver
    Eigentler, Thomas K.
    Grimm, Marc-Oliver
    Gruenwald, Victor
    Leipe, Jan
    Reinmuth, Niels
    Tietze, Julia K.
    Trojan, Joerg
    Zimmer, Lisa
    Gutzmer, Ralf
    CANCER TREATMENT REVIEWS, 2017, 57 : 36 - 49
  • [25] Inducing sensitivity to anti-PD-1 immune checkpoint blockade in murine models of melanoma and glioma
    Shim, K.
    Zaidi, S.
    Thompson, J.
    Kottke, T.
    Evgin, L.
    Rajani, K.
    Schuelke, M.
    Driscoll, C.
    Huff, A.
    Pulido, J.
    Vile, R.
    HUMAN GENE THERAPY, 2017, 28 (12) : A29 - A30
  • [26] Hydroxychloroquine synergizes with anti-PD-1 immune checkpoint blockade in squamous carcinoma of the head and neck
    Vyas, A.
    Cruz-Rangel, S.
    Khan, N.
    Ferris, R.
    Bruno, T.
    Schmitt, N.
    Kiselyov, K.
    Duvvuri, U.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S127 - S127
  • [27] Proteomic biomarker analysis of metastatic melanoma patients treated with anti-PD-1 checkpoint blockade
    Ascierto, Paolo Antonio
    Capone, Mariaelena
    Grimaldi, Antonio Maria
    Mallardo, Domenico
    Simeone, Ester
    Roder, Heinrich
    Meyer, Krista
    Asmellash, Senait
    Oliveira, Carlos
    Roder, Joanna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [28] Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
    Krueger, Janna
    Santinon, Francois
    Kazanova, Alexandra
    Issa, Mark E.
    Larrivee, Bruno
    Kremer, Richard
    Milhalcioiu, Catalin
    Rudd, Christopher E.
    PLOS ONE, 2021, 16 (06):
  • [29] DDR2 inhibition enhances response to anti-PD-1 immunotherapy
    Tu, Megan M.
    Lee, Francis Y.
    Jones, Robert T.
    Kimball, Abigail K.
    Saravia, Elizabeth
    Graziano, Robert F.
    Coleman, Brianne
    Menard, Krista
    Yan, Jun
    Michaud, Erin
    Chang, Han
    Abdel-Hafiz, Hany A.
    Rozhok, Andrii I.
    Duex, Jason E.
    Agarwal, Neeraj
    Chauca-Diaz, Ana
    Johnson, Linda K.
    Ng, Terry L.
    Cambier, John C.
    Clambey, Eric T.
    Costello, James C.
    Korman, Alan J.
    Theodorescu, Dan
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade is associated with induction of pro-inflammatory Tregs
    Rolig, Annah S.
    Sturgill, Elizabeth R.
    Mick, Courtney
    Rose, Daniel
    Kaufmann, Johanna
    Yanamandra, Niranjan
    Griffin, Sue
    Smothers, James
    Redmond, William L.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):